Temasek backs $55m Series A for US-based RNA gene therapy startup Locana

Temasek backs $55m Series A for US-based RNA gene therapy startup Locana

Locana, a California-based RNA-targeting gene therapy startup, has raised $55 million in its Series A funding round backed by existing investor Temasek Holdings, Singapore’s state-owned investment firm, according to an announcement.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter